Skip to main content

Age-Related Macular Degeneration: Dilated Macular Examination

CBE ID
0087
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
Next Maintenance Cycle
Fall 2024
1.3 Measure Description

Type of Score: Proportion

Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration (AMD) who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or hemorrhage AND the level of macular degeneration severity during one or more office visits within 12 months

        • 1.14 Numerator

          Patients who had a dilated macular examination performed which included documentation of the presence or absence of macular thickening or hemorrhage AND the level of macular degeneration severity during one or more office visits within 12 months

        • 1.15 Denominator

          All patients aged 50 years and older with a diagnosis of age-related macular degeneration

        • Exclusions

          Documentation of medical reason(s) for not performing a dilated macular examination

          Documentation of patient reason(s) for not performing a dilated macular examination

        • OLD 1.12 MAT output not attached
          Attached
          1.13a Data dictionary not attached
          No
        • Most Recent Endorsement Activity - OLD
          Endorsed EENT Endorsement Maintenance Project 2014
          Initial Endorsement
          Last Updated
        • Steward
          American Academy of Ophthalmology
          Steward Organization POC Email
          Steward Organization Copyright

          The Measures are not clinical guidelines, do not establish a standard of medical care, and have not been tested for all potential applications.

          The Measures, while copyrighted, can be reproduced and distributed, without modification, for noncommercial purposes, eg, use by health care providers in connection with their practices. Commercial use is defined as the sale, license, or distribution of the Measures for commercial gain, or incorporation of the Measures into a product or service that is sold, licensed or distributed for commercial gain.

          Commercial uses of the Measures require a license agreement between the user and the American Medical Association (AMA), [on behalf of the Physician Consortium for Performance Improvement® (PCPI®)] or the American Academy of Ophthalmology (AAO). Neither the AMA, AAO, PCPI, nor its members shall be responsible for any use of the Measures.

          The AMA’s and PCPI’s significant past efforts and contributions to the development and updating of the Measures is acknowledged. AAO is solely responsible for the review and enhancement (“Maintenance”) of the Measures as of May 15, 2014.

          AAO encourages use of the Measures by other health care professionals, where appropriate.

          THE MEASURES AND SPECIFICATIONS ARE PROVIDED “AS IS” WITHOUT WARRANTY OF ANY KIND.

          © 2014 American Medical Association and American Academy of Ophthalmology. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

              • Risk adjustment approach
                Off
                Risk adjustment approach
                Off
                Conceptual model for risk adjustment
                Off
                Conceptual model for risk adjustment
                Off